文献速递肺结节与肺癌

超细支气管镜联合径向支气管内超声与快速现场评估诊断外周肺病变的多中心随机析因试验

Ultrathin Bronchoscopy With Radial Endobronchial Ultrasound and Rapid On-Site Evaluation for the Diagnosis of Peripheral Pulmonary Lesions: A Multicenter Randomized Controlled Factorial Trial.
PubMed 文献 · Chest · 2025-05-24

该多中心2×2析因随机对照试验纳入181例外周肺病变患者,比较超细与非超细支气管镜联合径向支气管内超声、以及使用与不使用快速现场评估的诊断效能。结果显示两组诊断率与恶性肿瘤灵敏度均无显著差异,研究对较小差异把握度不足。

要点

  • 超细支气管镜与非超细支气管镜联合径向超声诊断率无显著差异。
  • 快速现场评估未显著提高径向超声诊断率或恶性肿瘤灵敏度。
  • 研究把握度不足以检测较小但可能有临床意义的差异。

核心结论

  • 超细支气管镜与非超细支气管镜联合径向支气管内超声诊断外周肺病变的诊断率及恶性肿瘤灵敏度无显著差异。
  • 使用快速现场评估与不使用相比,诊断率及恶性肿瘤灵敏度亦无显著差异。

研究设计与样本

  • 务实性多中心2×2析因随机对照试验,纳入成人外周肺病变(平均直径<5 cm)且影像学N0期并转诊支气管镜的患者。
  • 共评估215例,随机186例,分析181例;恶性肿瘤患病率84%。

主要发现

  • 非超细与超细支气管镜诊断率分别为65.6%与58.2%(差值-7.3%,P=.36),恶性肿瘤灵敏度分别为84.3%与74.3%(差值-10.0%,P=.21)。
  • 使用与不使用快速现场评估的诊断率分别为60.4%与63.5%(差值-3.1%,P=.76),恶性肿瘤灵敏度分别为80.3%与78.3%(差值2.0%,P=.83)。

临床怎么用

  • 在径向支气管内超声诊断外周肺病变时,超细支气管镜与快速现场评估未显示额外诊断获益。
  • 临床选择超细支气管镜或快速现场评估应结合其他因素,而非仅期望提高诊断率。

局限性

  • 研究把握度不足,无法检测较小但可能有临床意义的差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The routine use of CT imaging and lung cancer screening has increased the identification of peripheral pulmonary lesions (PPLs). Sampling may be needed for some nodules. Many new technologies are available to improve the diagnostic performance of bronchoscopy for the sampling of PPLs, but few comparative trials exist. The objective of this study was to compare the diagnostic performance of bronchoscopy with radial endobronchial ultrasound (rEBUS) using an ultrathin bronchoscope (BF-MP190F; Olympus) with a non-ultrathin bronchoscope and to compare the diagnostic performance of bronchoscopy with and without rapid on-site evaluation (ROSE). RESEARCH QUESTION: Does diagnostic performance differ between ultrathin and non-ultrathin bronchoscopes with rEBUS, and what impact does ROSE have on diagnostic performance of rEBUS? STUDY DESIGN AND METHODS: This pragmatic, multicenter, 2 × 2 factorial, randomized controlled trial involved adult patients with PPLs (mean diameter < 5 cm) and radiographic stage N0 disease referred for bronchoscopy. The study was powered to detect a 20% improvement in the primary outcome of difference in diagnostic yield (DY) between ultrathin and non-ultrathin bronchoscopes and between procedures with and without ROSE. Secondary outcomes included sensitivity for malignancy, complications, and procedure duration. RESULTS: Of 215 patients assessed, 186 patients were randomized and 181 patients were analyzed. Malignancy prevalence was 84%. No significant differences in DY or sensitivity for malignancy were found between non-ultrathin and ultrathin bronchoscopes: 65.6% vs 58.2% (difference, -7.3%; P = .36) and 84.3% vs 74.3% (difference, -10.0%; P = .21), respectively. Similarly, no significant differences were observed with or without ROSE: 60.4% vs 63.5% (difference, -3.1%; P = .76) and 80.3% vs 78.3% (difference, 2.0%; P = .83), respectively. INTERPRETATION: We could not identify a difference in DY or sensitivity for malignancy for the diagnosis of PPLs between an ultrathin bronchoscope and a non-ultrathin bronchoscope and between ROSE and no ROSE. The study was underpowered to detect smaller but potentially clinically meaningful differences. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov; No.: NCT03809169; URL: www. CLINICALTRIALS: gov.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Vakil E, Fortin M, Gonzalez AV, et al. Ultrathin Bronchoscopy With Radial Endobronchial Ultrasound and Rapid On-Site Evaluation for the Diagnosis of Peripheral Pulmonary Lesions: A Multicenter Randomized Controlled Factorial Trial. Chest. 2025. PMID: 40419109. doi:10.1016/j.chest.2025.05.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。